Michel F. Martínez‐Reséndez

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

Activity of sertraline against<i>Cryptococcus neoformans</i>:<i>in vitro</i>and<i>in vivo</i>assays

Rogelio de J. Treviño‐Rangel, Hiram Villanueva‐Lozano, Pedro A. Hernández-Rodríguez et al. · Medical Mycology · 2015 · 63 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Impact of daily chlorhexidine baths and hand hygiene compliance on nosocomial infection rates in critically ill patients

Michel F. Martínez‐Reséndez, Elvira Garza‐González, Soraya Mendoza-Olazarán et al. · American Journal of Infection Control · 2014 · 50 citations

Public Health, Critical Care Nursing, Infectious Diseases +17

Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience

Hiram Villanueva‐Lozano, Rogelio de J. Treviño‐Rangel, Gloria M. González et al. · Infection · 2017 · 34 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Initial experience in Mexico with convalescent plasma in COVID-19 patients with severe respiratory failure, a retrospective case series

Michel F. Martínez‐Reséndez, Fernando Castilleja‐Leal, Alejandro Torres‐Quintanilla et al. · medRxiv · 2020 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17